Zenflow Patents

Patent portfolio assigned to Zenflow (verified via public assignee records). Estimated patent count: 4. BPH urethral-implant medtech (Spring System, FDA approved 2025). Competitors are other minimally invasive BPH devices. Patents assigned to Zenflow, Inc. confirmed via Google Patents search (US10912637B2, US11771575B2, US11890213B2, WO2021101951A1); count is an estimate of visible filings. No named customers (device sold to clinicians/hospitals, none named on public pages).